All practices | Traditional | Corporate | PHO/DHB | Trust/NGO | Māori | Pacific | HCH | |
---|---|---|---|---|---|---|---|---|
N enrolled a | 3622 2074–6189 | 3597 2040–5971 | 5527 3133–9858 | 3642 1990–6865 | 2712 1528–4985 | 2954 1528–4975 | 2356 1722–5141 | 5750 3822–9502 |
Age ≤ 14 b | 19% 17–22 | 19% 16–22 | 21% 17–25 | 21% 17–25 | 23% 20–26 | 25% 22–27 | 25% 23–28 | 20% 18–22 |
Age ≥ 65 b | 16% 12–21 | 19% 16–22 | 21% 17–25 | 21% 17–25 | 23% 20–26 | 11% 8–15 | 9% 6–12 | 16% 12–20 |
Māori b | 10% 6–17 | 9% 5–14 | 11% 7–18 | 11% 8–23 | 34% 10–71 | 62% 35–77 | 8% 6–13 | 10% 6–18 |
Pacific b | 2% 1–5 | 2% 1–4 | 3% 1–10 | 2% 1–3 | 3% 1–11 | 4% 2–9 | 68% 32–84 | 2% 1–5 |
Quintile 5 b | 12% 4–29 | 11% 4–21 | 17% 7–32 | 13% 3–35 | 47% 23–65 | 58% 38–72 | 46% 36–66 | 11% 5–23 |
IMD a | 2882 2191–3775 | 2707 2095–3473 | 3205 2406–3945 | 2902 2340–3972 | 4331 3445–4901 | 4568 3987–5030 | 4623 3735–4906 | 2798 1917–3569 |
With diabetes b | 5% 4–7 | 5% 4–6 | 5% 4–7 | 5% 4–6 | 7% 6–8 | 8% 7–9 | 11% 7–13 | 5% 4–6 |
Dispensed SSRI in last year b | 7% 5–8 | 7% 6–9 | 7% 4–8 | 7% 5–8 | 5% 3–7 | 4% 3–7 | 3% 1–4 | 8% 7–9 |
Dispensed antibiotic in last year b | 40% 35–44 | 40% 35–44 | 40% 37–45 | 38% 33–41 | 39% 32–44 | 42% 37–45 | 47% 44–50 | 38% 34–40 |
M3 a | 0.14 0.11–0.16 | 0.13 0.11–0.16 | 0.13 0.11–0.15 | 0.13 0.10–0.16 | 0.18 0.14–0.19 | 0.18 0.16–0.21 | 0.16 0.13–0.19 | 0.14 0.12–0.17 |
Non-continuity of practice b | 21% 17–27 | 20% 16–26 | 23% 18–31 | 22% 18–26 | 25% 19–32 | 27% 21–33 | 33% 24–42 | 21% 17–27 |
Distance to nearest ED c | 7.4 | 7.3 | 6.7 | 12.7 | 9.4 | 8.7 | 5.4 | 8.1 |
FTE nurse: 1000 enrolled patients a | 0.54 0.38–0.72 | 0.51 0.37–0.68 | 0.58 0.38–0.71 | 0.64 0.47–0.77 | 0.90 0.67–1.01 | 0.79 0.68–0.97 | 0.87 0.67–0.96 | 0.59 0.50–0.80 |
FTE GP: 1000 enrolled patients a | 0.63 0.51–0.79 | 0.63 0.51–0.80 | 0.60 0.51–0.72 | 0.63 0.51–0.65 | 0.69 0.51–1.00 | 0.68 0.55–0.90 | 0.67 0.57–1.01 | 0.60 0.52–0.77 |